0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Remediation Sign in to save

Environmental Impact of Treatment of Pharmaceutical Packaging Materials

International Journal of Natural Resources and Environmental Studies 2024 Score: 45 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Jiayang Li

Summary

Researchers assessed the environmental impact of treating pharmaceutical packaging materials at end of life, comparing incineration, recycling, and landfill pathways for plastics used in medicine packaging.

In this paper, LCA method is used to explore how a certain material or a specific drug packaging waste enters the environment after different garbage disposal methods, and what impact it has on the population and community after entering the environment. Pharmaceutical packaging materials are unavoidable in human life a class of materials, the international market for product packaging increasingly strict environmental requirements, China's drug manufacturers and pharmaceutical packaging industry put forward more severe requirements, in such a situation, the drug packaging to achieve effective recycling and pollution prevention is China's drug manufacturers must face the problem. The domestic research direction is mainly LCA, and the development and application of green packaging materials and new pharmaceutical packaging materials. The international research also includes carbon footprint estimation and LCM of pharmaceutical packaging, as well as innovation in recycling technology.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Quantification of Microplastics from Primary Drug Packaging Materials

Researchers developed and validated a standardized multi-modal analytical framework to quantify microplastics shed from primary pharmaceutical packaging materials — including PVC, PET, PP, and HDPE — under mechanical, thermal, and photolytic stress, revealing a previously underquantified source of human microplastic exposure.

Article Tier 2

Micro-plastics as a source of contaminaion in pharmaceuticals

This review examined how microplastics contaminate pharmaceutical manufacturing environments and products, discussing the potential health risks of plastic particle exposure through medicines and the pathways by which microplastics enter pharmaceutical supply chains.

Systematic Review Tier 1

Plastic particles in medicine: A systematic review of exposure and effects to human health

Medical plastics including bags, containers, and administration sets release micro- and nanoplastics along with chemical additives that can interact with pharmaceutical constituents, creating an understudied route of direct human exposure. Both primary exposure (during medical treatment) and secondary environmental exposure (from hospital plastic waste disposal) represent potential health hazards.

Article Tier 2

Medical Household Waste as a Potential Environmental Hazard: An Ecological and Epidemiological Approach

Researchers investigated household pharmaceutical waste disposal practices and analyzed drug residues in water bodies near Mexico's largest urban population, identifying frequently detected medications and assessing associated environmental and health risks.

Article Tier 2

Impact of Pharmaceutical Waste Generation and Handling on Environmental Health in Developing Countries: COVID – 19 Pandemic in Perspective!

This paper examines how pharmaceutical waste generation and handling during the COVID-19 pandemic exacerbated environmental health risks in developing countries, where inadequate waste management infrastructure led to increased contamination of soil and water.

Share this paper